SEROTONINE
ActiveSummary
SEROTONINE has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2,600 and a net result of €52,216. Equity is shrinking by about 33% per year across the filed financial years. Its solvency ranks better than 10% of 20,844 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
19-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2018 to 2025net €52,216 ▲3.8%
Operating result €67,504, net result €52,216, both a record.
20-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
14-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
16-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
17-06
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
18-06
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
19-06
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
14-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
14-06
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
16-06
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.